Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs
Current medical treatments against recurrent pulmonary infections caused by <i>Pseudomonas aeruginosa</i>, such as cystic fibrosis (CF) disorder, involve the administration of inhalable antibiotics. The main challenge is, however, the eradication of microbial biofilms immersed in dense m...
Guardado en:
| Autores principales: | Islan, Germán Abel, Ruiz, María Esperanza, Morales, Juan Francisco, Sbaraglini, María Laura, Enrique, Andrea Verónica, Burton, Gerardo, Talevi, Alan, Bruno Blanch, Luis Enrique, Castro, Guillermo Raúl |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/147827 |
| Aporte de: |
Ejemplares similares
-
Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: Physicochemical characterization and in vivo targeted delivery to the lungs
por: Islan, G.A., et al. -
Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: Physicochemical characterization and in vivo targeted delivery to the lungs
por: Burton, Gerardo, et al.
Publicado: (2017) -
Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
por: Islan, Germán Abel, et al.
Publicado: (2016) -
Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: Physicochemical characterization and in vivo targeted delivery to the lungs
por: Islan, G.A
Publicado: (2017) -
High concentrations of sodium chloride improve microbicidal activity of ibuprofen against common cystic fibrosis pathogens
por: Muñoz, Adrián, et al.
Publicado: (2023)